source
- Repligen to acquire BioLife Solutions for $1.5 billion, boosting its role in cell therapy preservationRepligen announced a $1.5 billion acquisition of BioLife Solutions, a company whose CryoStor media is used to preserve cell therapies during storage and transport. BioLife’s products are employed…
- Crystalys Therapeutics raises $130M Series B to advance gout drug dotinurad toward global launchCrystalys Therapeutics announced a $130 million Series B financing to move its gout drug dotinurad through late-stage trials and prepare for commercial launch. The round was led by Frazier Life Sc…